Artiva Biotherapeutics Inc
ARTVLatest QuantConomy context for ARTV: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Artiva Biotherapeutics Inc
QuantConomy has a structured record for ARTV. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- ARTV
- Name
- Artiva Biotherapeutics Inc
- Coverage
- 3 market/data records
- Sources
- alphavantage alpaca fmp sec nasdaq
Recent signals for ARTV
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| downtrend | bearish | 37 | Jun 30, 03:06 PM | ARTV downtrend (drop): price -1.87% (strength 37, current 9.72) |
| uptrend | slightly bullish | 29 | Jun 30, 02:12 PM | ARTV uptrend (gain): price 1.45% (strength 29, current 9.81) |
| uptrend | bullish | 32 | Jun 30, 01:34 PM | ARTV uptrend (gain): price 1.58% (strength 32, current 9.94) |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
OWNERSHIP signals are experimental: historical 13D/G coverage is still being backfilled, so results may be sparse or empty.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| ARTV | NASDAQ | alphavantage | Artiva Biotherapeutics Inc |
| ARTV | NASDAQ | alpaca | Artiva Biotherapeutics, Inc. Common Stock |
| ARTV | NASDAQ | fmp | Artiva Biotherapeutics, Inc. |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | purchase | 31,000 | $8.88 | $275,280 | 4 on EDGAR |
| Jun 12, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | purchase | 391,019 | $8.57 | $3,351,033 | 4 on EDGAR |
| Jun 9, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | purchase | 479,039 | $6.91 | $3,310,159 | 4 on EDGAR |
| May 19, 2026 | Raymon Heather | SVP, Research and Development | sale | 3,095 | $9.01 | $27,879 | 4 on EDGAR |
| May 19, 2026 | Horan Christopher | Chief Tech Operations Officer | sale | 7,002 | $9.01 | $63,073 | 4 on EDGAR |
| May 19, 2026 | Bush Jennifer | COO, CLO, Compliance Officer | sale | 8,790 | $9.01 | $79,179 | 4 on EDGAR |
| May 19, 2026 | Banerjee Subhashis | Chief Medical Officer | sale | 7,037 | $9.01 | $63,386 | 4 on EDGAR |
| May 19, 2026 | Aslan Fred | Chief Executive Officer | sale | 27,116 | $9.01 | $244,253 | 4 on EDGAR |
| May 18, 2026 | Miralles Gines Diego | President & Head of R&D | grant | 77,500 | $0.00 | $0 | 4 on EDGAR |
| May 11, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | purchase | 6,510,416 | $11.52 | $74,999,992 | 4 on EDGAR |
| May 11, 2026 | GC Corp. | 10% owner | purchase | 1,085,069 | $11.52 | $12,499,995 | 4 on EDGAR |
| Mar 10, 2026 | Huston Thad Allen | Chief Financial Officer | grant | 220,000 | $0.00 | $0 | 4 on EDGAR |
| Feb 18, 2026 | Sorg Elaine K. | Director | grant | 27,500 | — | — | 4 on EDGAR |
| Dec 12, 2025 | Bush Jennifer | COO, CLO, Secy, Compliance Off | grant | 84,877 | $0.00 | $0 | 4 on EDGAR |
| Dec 12, 2025 | Aslan Fred | President and CEO | grant | 869,136 | $0.00 | $0 | 4 on EDGAR |
| Dec 12, 2025 | Raymon Heather | SVP, Research and Development | grant | 67,253 | $0.00 | $0 | 4 on EDGAR |
| Dec 12, 2025 | Horan Christopher | Chief Tech Operations Officer | grant | 107,156 | $0.00 | $0 | 4 on EDGAR |
| Nov 15, 2025 | Raymon Heather | SVP, Research and Development | other | 1,375 | $3.25 | $4,469 | 4 on EDGAR |
| Nov 15, 2025 | Bush Jennifer | COO, CLO, Secy, Compliance Off | other | 3,055 | $3.25 | $9,929 | 4 on EDGAR |
| Nov 15, 2025 | Aslan Fred | President and CEO | other | 6,347 | $3.25 | $20,628 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query ARTV context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access